Cargando…
Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins
BACKGROUND: Little is known about patients with cancer presenting with acute chest discomfort to the emergency department (ED). OBJECTIVES: The aim of this study was to assess the prevalence of acute myocardial infarction (AMI), outcomes, and the diagnostic utility of recommended diagnostic tools in...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635894/ https://www.ncbi.nlm.nih.gov/pubmed/37969646 http://dx.doi.org/10.1016/j.jaccao.2023.08.001 |
_version_ | 1785146382773911552 |
---|---|
author | Bima, Paolo Lopez-Ayala, Pedro Koechlin, Luca Boeddinghaus, Jasper Nestelberger, Thomas Okamura, Bernhard Muench-Gerber, Tamar S. Sanzone, Alessandra Skolozubova, Daria Djurdjevic, David Rubini Gimenez, Maria Wildi, Karin Miro, Oscar Martínez-Nadal, Gemma Martin-Sanchez, Francisco J. Christ, Michael Keller, Dagmar Lindahl, Bertil Giannitsis, Evangelos Mueller, Christian |
author_facet | Bima, Paolo Lopez-Ayala, Pedro Koechlin, Luca Boeddinghaus, Jasper Nestelberger, Thomas Okamura, Bernhard Muench-Gerber, Tamar S. Sanzone, Alessandra Skolozubova, Daria Djurdjevic, David Rubini Gimenez, Maria Wildi, Karin Miro, Oscar Martínez-Nadal, Gemma Martin-Sanchez, Francisco J. Christ, Michael Keller, Dagmar Lindahl, Bertil Giannitsis, Evangelos Mueller, Christian |
author_sort | Bima, Paolo |
collection | PubMed |
description | BACKGROUND: Little is known about patients with cancer presenting with acute chest discomfort to the emergency department (ED). OBJECTIVES: The aim of this study was to assess the prevalence of acute myocardial infarction (AMI), outcomes, and the diagnostic utility of recommended diagnostic tools in this population. METHODS: Patients presenting with chest pain to the ED were prospectively enrolled in an international multicenter diagnostic study with central adjudication. Cancer status was assessed prospectively and additional cancer details retrospectively. Findings were externally validated in an independent multicenter cohort. RESULTS: Among 8,267 patients, 711 (8.6%) had cancer. Patients with cancer had a higher burden of cardiovascular risk factors and pre-existing cardiac disease. Total length of stay in the ED (5.2 hours vs 4.3 hours) and hospitalization rate (49.8% vs 34.3%) were both increased in patients with cancer (P < 0.001 for both). Among 8,093 patients eligible for the AMI analyses, those with cancer more often had final diagnoses of AMI (184 of 686 with cancer [26.8%] vs 1,561 of 7,407 without cancer [21.1%]; P < 0.001). In patients with cancer, high-sensitivity cardiac troponin T (hs-cTnT) but not high sensitivity cardiac troponin I (hs-cTnI) concentration had lower diagnostic accuracy for non–ST-segment elevation myocardial infarction (for hs-cTnT, area under the curve: 0.89 [95% CI: 0.86-0.92] vs 0.94 [95% CI: 0.93-0.94] [P < 0.001]; for hs-cTnI, area under the curve: 0.93 [95% CI: 0.91-0.95] vs 0.95 [95% CI: 0.94-0.95] [P = 0.10]). In patients with cancer, the European Society of Cardiology 0/1-hour hs-cTnT and hs-cTnI algorithms maintained very high safety but had lower efficacy, with twice the number of patients remaining in the observe zone. Similar findings were obtained in the external validation cohort. CONCLUSIONS: Patients with cancer have a substantially higher prevalence of AMI as the cause of chest pain. Length of ED stay and hospitalization rates are increased. The diagnostic performance of hs-cTnT and the efficacy of both the European Society of Cardiology 0/1-hour hs-cTnT and hs-cTnI algorithms is reduced. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE] Study; NCT00470587) |
format | Online Article Text |
id | pubmed-10635894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-106358942023-11-15 Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins Bima, Paolo Lopez-Ayala, Pedro Koechlin, Luca Boeddinghaus, Jasper Nestelberger, Thomas Okamura, Bernhard Muench-Gerber, Tamar S. Sanzone, Alessandra Skolozubova, Daria Djurdjevic, David Rubini Gimenez, Maria Wildi, Karin Miro, Oscar Martínez-Nadal, Gemma Martin-Sanchez, Francisco J. Christ, Michael Keller, Dagmar Lindahl, Bertil Giannitsis, Evangelos Mueller, Christian JACC CardioOncol Original Research BACKGROUND: Little is known about patients with cancer presenting with acute chest discomfort to the emergency department (ED). OBJECTIVES: The aim of this study was to assess the prevalence of acute myocardial infarction (AMI), outcomes, and the diagnostic utility of recommended diagnostic tools in this population. METHODS: Patients presenting with chest pain to the ED were prospectively enrolled in an international multicenter diagnostic study with central adjudication. Cancer status was assessed prospectively and additional cancer details retrospectively. Findings were externally validated in an independent multicenter cohort. RESULTS: Among 8,267 patients, 711 (8.6%) had cancer. Patients with cancer had a higher burden of cardiovascular risk factors and pre-existing cardiac disease. Total length of stay in the ED (5.2 hours vs 4.3 hours) and hospitalization rate (49.8% vs 34.3%) were both increased in patients with cancer (P < 0.001 for both). Among 8,093 patients eligible for the AMI analyses, those with cancer more often had final diagnoses of AMI (184 of 686 with cancer [26.8%] vs 1,561 of 7,407 without cancer [21.1%]; P < 0.001). In patients with cancer, high-sensitivity cardiac troponin T (hs-cTnT) but not high sensitivity cardiac troponin I (hs-cTnI) concentration had lower diagnostic accuracy for non–ST-segment elevation myocardial infarction (for hs-cTnT, area under the curve: 0.89 [95% CI: 0.86-0.92] vs 0.94 [95% CI: 0.93-0.94] [P < 0.001]; for hs-cTnI, area under the curve: 0.93 [95% CI: 0.91-0.95] vs 0.95 [95% CI: 0.94-0.95] [P = 0.10]). In patients with cancer, the European Society of Cardiology 0/1-hour hs-cTnT and hs-cTnI algorithms maintained very high safety but had lower efficacy, with twice the number of patients remaining in the observe zone. Similar findings were obtained in the external validation cohort. CONCLUSIONS: Patients with cancer have a substantially higher prevalence of AMI as the cause of chest pain. Length of ED stay and hospitalization rates are increased. The diagnostic performance of hs-cTnT and the efficacy of both the European Society of Cardiology 0/1-hour hs-cTnT and hs-cTnI algorithms is reduced. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE] Study; NCT00470587) Elsevier 2023-08-26 /pmc/articles/PMC10635894/ /pubmed/37969646 http://dx.doi.org/10.1016/j.jaccao.2023.08.001 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Bima, Paolo Lopez-Ayala, Pedro Koechlin, Luca Boeddinghaus, Jasper Nestelberger, Thomas Okamura, Bernhard Muench-Gerber, Tamar S. Sanzone, Alessandra Skolozubova, Daria Djurdjevic, David Rubini Gimenez, Maria Wildi, Karin Miro, Oscar Martínez-Nadal, Gemma Martin-Sanchez, Francisco J. Christ, Michael Keller, Dagmar Lindahl, Bertil Giannitsis, Evangelos Mueller, Christian Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins |
title | Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins |
title_full | Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins |
title_fullStr | Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins |
title_full_unstemmed | Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins |
title_short | Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins |
title_sort | chest pain in cancer patients: prevalence of myocardial infarction and performance of high-sensitivity cardiac troponins |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635894/ https://www.ncbi.nlm.nih.gov/pubmed/37969646 http://dx.doi.org/10.1016/j.jaccao.2023.08.001 |
work_keys_str_mv | AT bimapaolo chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT lopezayalapedro chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT koechlinluca chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT boeddinghausjasper chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT nestelbergerthomas chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT okamurabernhard chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT muenchgerbertamars chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT sanzonealessandra chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT skolozubovadaria chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT djurdjevicdavid chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT rubinigimenezmaria chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT wildikarin chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT mirooscar chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT martineznadalgemma chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT martinsanchezfranciscoj chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT christmichael chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT kellerdagmar chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT lindahlbertil chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT giannitsisevangelos chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT muellerchristian chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins AT chestpainincancerpatientsprevalenceofmyocardialinfarctionandperformanceofhighsensitivitycardiactroponins |